ArticlePreventive medicine2026
Beliefs about non-cigarette tobacco products for cigarette smoking cessation among U.S. adults.
Article in Preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo examine the associations of sociodemographic characteristics, tobacco use, and digital media engagement, with beliefs about the use of non-cigarette tobacco products to help people quit smoking cigarettes among U.S. adults.
methodsWe analyzed data from the 2024 Health Information National Trends Survey (March-September 2024), a cross-sectional, nationally representative survey of U.S adults. Weighted bivariate analyses and multivariable logistic regression examined beliefs that non-cigarette tobacco products can help people quit smoking by sociodemographic characteristics, tobacco use, and digital media engagement.
resultsNearly 22% believed no products could help people quit, 20.9% believed at least one product could, and 57.4% reported uncertainty. In multivariable models, ever use of e-cigarettes (adjusted odds ratio [aOR], 3.32; 95% confidence interval [CI], 2.32,4.74) and modified risk tobacco products (aOR, 10.43; 95%CI, 6.27,32.7) were associated with higher odds of cessation beliefs for that product compared to those who had never used it. Differences also emerged by age, sex, and digital media engagement.
conclusionsThese findings indicate the need for accurate and consistent communication to help the public better understand non-cigarette tobacco products and increase awareness of evidence-based smoking cessation aids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.